ArticleFrontiers in microbiology2019
Characterization of Five
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- The flexible cotransfer of plasmids drives the dissemination of tet(X4) in swine Escherichia coli.Veterinary research · 2026Article
- Co-occurrence of plasmid-mediated colistin resistance gene, mcr-1 and blaScientific reports · 2026Article
- Polymyxin-Resistant Escherichia coli Found in Vegetables from Brazil: An Emerging Public Health Concern.Current microbiology · 2026Article
- The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review.Antibiotics (Basel, Switzerland) · 2025Review
- Co-resistance and plasmid-mediated co-dissemination of florfenicol and azithromycin resistance in non-O157 Shiga toxin-producing Escherichia coli from cattle in Xinjiang, China.BMC microbiology · 2025Article
- Whole genome analysis of multidrug-resistantMicrobiology spectrum · 2024Article
- Antimicrobial consumption and resistance in bacteria from humans and food-producing animals: Fourth joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA JIACRA IV - 2019-2021.EFSA journal. European Food Safety Authority · 2024Article
- Identification and Genomic Analyses of a Multidrug Resistant Avian PathogenicTransboundary and emerging diseases · 2024Article
- Mobile Colistin Resistance (Antibiotics (Basel, Switzerland) · 2023Review
- Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023Article
- Emergence of colistin resistance and characterization of antimicrobial resistance and virulence factors ofPeerJ · 2023Article
- High Prevalence and Persistence of Escherichia coli Strains Producing Shiga Toxin Subtype 2k in Goat Herds.Microbiology spectrum · 2022Article
- Mobile Colistin Resistance (Pathogens (Basel, Switzerland) · 2022Review
- Worldwide Prevalence ofPathogens (Basel, Switzerland) · 2022Review
- Spreading Advantages of Coresident PlasmidsMicrobiology spectrum · 2022Article
- Molecular Epidemiology of New Delhi Metallo-Frontiers in microbiology · 2022Article
- Occurrence ofMicrobiology insights · 2022Article
- Characteristics of the plasmid-mediated colistin-resistance geneFrontiers in microbiology · 2022Article
- Pan-Resistome Characterization of UropathogenicAntibiotics (Basel, Switzerland) · 2021Article
- Genomic Characteristics of Stx2e-ProducingPathogens (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Present study characterized five
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.